Atlas Trials

An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects

Clinical trial NCT04241393 · COMPLETED

Trial details

NCT number
NCT04241393
Sponsor
Cerevel Therapeutics, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2020-02-04
Primary completion
2020-11-08
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.